News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Company News

Cardinal Health Holds Annual Meeting, Releases Preliminary Shareholder Voting Results
11/04/2009

Board of Directors Declares Regular Quarterly Dividend

DUBLIN, Ohio, Nov. 4, 2009 /PRNewswire-FirstCall/ — Cardinal Health today released the preliminary results of shareholder voting at its annual meeting of shareholders, and the board of directors declared the company's 101st consecutive regular quarterly dividend.

Based on the preliminary voting results, shareholders elected 10 directors to the board, ratified Ernst & Young as the company's independent registered public accounting firm and re-approved the performance criteria under the company's management incentive plan. Shareholder proposals relating to performance-based stock options and requiring an independent chairman of the board did not pass. Final results will be posted on the investor page at cardinalhealth.com

Separately, the board of directors declared a regular quarterly dividend of $0.175 per share, payable on Jan. 15, 2010 to shareholders of record on Jan. 1, 2010. For more than 25 years, Cardinal Health has paid a regular quarterly dividend. The company had approximately 363 million shares outstanding as of Oct. 31.


About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a Fortune 18 health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals and ambulatory care sites focus on patient care while reducing costs, improving efficiency and quality, and increasing profitability. As one of the largest health care companies in the world, Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products to more than 40,000 locations each day. The company is also a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company supports the growing diagnostic industry by supplying medical products to clinical laboratories and operating the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Cardinal Health employs more than 30,000 people worldwide. More information about the company may be found at cardinalhealth.com.

SOURCE: Cardinal Health, Inc.
Website: cardinalhealth.com

More Company News
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

04/07/2021

By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health

04/07/2021

Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...

03/30/2021

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields